United States · FDA National Drug Code directory
BIXLENVO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61958-3601_1da44bad-4470-4f3d-b7b2-bc3730f496d1
- Product NDC
- 61958-3601
- Form
- TABLET, FILM COATED
- Composition / generic term
- bictegravir/lenacapavir
- Labeler
- Gilead Sciences, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260827
- Source listing expiry
- 20271231
Source-listed ingredients
- BICTEGRAVIR SODIUM — 75 mg/1
- LENACAPAVIR SODIUM — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3601-1) · 61958-3601-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →